Skip to main content

Peer Review reports

From: "Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

Original Submission
21 May 2010 Submitted Original manuscript
25 May 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 2
25 May 2010 Submitted Manuscript version 2
19 Jul 2010 Reviewed Reviewer Report - bruno vincenzi
20 Jul 2010 Reviewed Reviewer Report - Gilberto de Lima Lopes
20 Aug 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 3
20 Aug 2010 Submitted Manuscript version 3
20 Aug 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 4
20 Aug 2010 Submitted Manuscript version 4
20 Aug 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 5
20 Aug 2010 Submitted Manuscript version 5
20 Aug 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 6
20 Aug 2010 Submitted Manuscript version 6
26 Aug 2010 Reviewed Reviewer Report - Gilberto de Lima Lopes
14 Sep 2010 Reviewed Reviewer Report - bruno vincenzi
16 Oct 2010 Author responded Author comments - Gemma Bruera
Resubmission - Version 7
16 Oct 2010 Submitted Manuscript version 7
Publishing
19 Oct 2010 Editorially accepted
19 Oct 2010 Article published 10.1186/1471-2407-10-567

You can find further information about peer review here.

Back to article page